HomePTGX • NASDAQ
add
Protagonist Therapeutics Inc
Previous close
$31.47
Day range
$31.14 - $32.01
Year range
$13.72 - $33.34
Market cap
1.87B USD
Avg Volume
522.77K
P/E ratio
12.99
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 254.95M | — |
Operating expense | 48.64M | 35.04% |
Net income | 207.34M | 714.80% |
Net profit margin | 81.32 | — |
Earnings per share | 3.26 | 586.57% |
EBITDA | 206.54M | 677.38% |
Effective tax rate | 1.58% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 322.64M | 39.81% |
Total assets | 629.28M | 162.35% |
Total liabilities | 68.83M | 190.54% |
Total equity | 560.44M | — |
Shares outstanding | 58.65M | — |
Price to book | 3.29 | — |
Return on assets | 104.49% | — |
Return on capital | 114.78% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 207.34M | 714.80% |
Cash from operations | -27.43M | 20.14% |
Cash from investing | 6.07M | -38.21% |
Cash from financing | 7.20M | -72.80% |
Net change in cash | -14.16M | -829.09% |
Free cash flow | -132.77M | -520.53% |
About
Founded
2006
Headquarters
Website
Employees
124
